Fangxiao Chen

Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study

Xin Zhang, Yansong Lin, N. Niu, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study

Jingwen Xu, Xin Zhang, Yansong Lin, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Modulating calcium‐mediated NFATc1 and mitogen‐activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption

Jiake Xu, R. Tan, Jennifer Tickner, 2018, Journal of cellular physiology.